強瑞技術(301128.SZ):已通過立訊精密向部分客戶提供工業領域使用的機器人相關產品
格隆匯3月3日丨強瑞技術(301128.SZ)在接受機構調研時表示,公司目前已經通過立訊精密向部分客戶提供工業領域使用的機器人相關產品,只是目前訂單金額很小,不會對公司的業務形成較大影響。公司認爲隨着人工智能的不斷普及和深化,機器人相關業務是公司未來的研發突破方向,公司正積極佈局與機器人相關的核心零部件產品(如核心關節)及檢測設備等業務,並正在與潛在客戶進行方案對接及送樣,但最終能否形成有效訂單,仍具有不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.